#21: Are phage-derived enzymes the future of disease control? episode artwork

EPISODE · Sep 7, 2023 · 17 MIN

#21: Are phage-derived enzymes the future of disease control?

from Arqus Knowledge Pills · host Arqus European University Alliance

For the 22nd episode of the Arqus Knowledge Pills, we talked to Zuzanna Drulis-Kawa from the University of Wrocław. She is a Professor at and head of the Department of Pathogen Biology and Immunology at the Faculty of Biological Sciences. In this episode, she helps us understand what phage-derived enzymes are. They can be used as an alternative to antibiotics in fighting illnesses and represent hope against antibiotic resistance. Zuzanna explains how the enzymes work and gives us examples of their application in current medicine.

Episode metadata supplied by the publisher feed · Published Sep 7, 2023

Embed this episode

Ready to play

#21: Are phage-derived enzymes the future of disease control?

0:00 17:41

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Arqus Knowledge Pills?

This episode is 17 minutes long.

When was this Arqus Knowledge Pills episode published?

This episode was published on September 7, 2023.

Can I download this Arqus Knowledge Pills episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!